期刊文献+

柔毛淫羊藿对去卵巢小鼠骨密度、破骨细胞和IL-1β的影响 被引量:7

Effects of Epimedium pubescens Maxim. on Osteoporosis in Ovariectomized Mouse
原文传递
导出
摘要 目的:探讨单味中药柔毛淫羊藿(EPM)对去卵巢小鼠骨密度、破骨细胞和白介素-1β(IL-1β)的影响。方法:切除雌性小鼠双侧卵巢制备骨质疏松动物模型,随机分为模型组、己烯雌酚(DES,2 mg.kg-1)组及EPM水煎浸膏高、中、低剂量(200,100,50 mg.kg-1)组,另设正常对照组。术后45 d开始给予相应药物,1次/d,60 d后检测小鼠骨组织骨密度、破骨细胞数和骨组织中IL-1β。结果:模型组动物呈现明显的骨质疏松表现;给药组动物骨密度增加;EPM高、中、低剂量骨组织破骨细胞数分别为(1.9±1.0),(0.9±0.6),(0.8±0.4)个,明显低于模型组(3.4±1.6)个,(P<0.05或P<0.01);EPM高、中、低剂量骨组织IL-1β阳性细胞数分别为(11.6±2.1),(12.4±2.2),(16.4±2.7)个,明显低于模型组(20.6±3.2)个(P<0.01)。结论:EPM能增加去卵巢骨质疏松症小鼠的骨密度、降低破骨细胞数和IL-1β的表达。 Objective : To investigate the effect of Epimedium pubescens Maxim. (EPM) on osteoporosis in ovariectomized mouse. Method: Kunming mice were used in this study. Osteoposis model was estabished by ectomizing the ovarians of the mice. The mice were divided into six groups randomly : control group, model group, diethylstilbestrol positive control group, high dose of EPM group (200 mg. kg-1 ), middle dose of EPM group (100 mg . kg-1) and low dose of EPM group (50 mg . kg-1). Sixty days after administration, bone density, the osteoclast and intelukin (IL-1β) of the bone tissue were measured. Result: The model group animals had obvious osteoporosis. EMP increased bone density, and decreased the osteoclast number and IL-1β obviously. Conlusion: EPM can increase the bone density. EPM has an apparent role of anti-osteoporosis in ovariectomized mice. And it' s mechanism may be related to the reducing of the level of IL-1β.
出处 《中国实验方剂学杂志》 CAS 北大核心 2012年第6期241-243,共3页 Chinese Journal of Experimental Traditional Medical Formulae
关键词 柔毛淫羊藿 骨质疏松 白细胞介素-1Β 骨密度 Epimedium pubescens Maxim. osteoporosis intelukin-1β bone density
  • 相关文献

参考文献10

  • 1.中国药典一部[S].,2005版.352.
  • 2Nakamuta H.The ovariectomized animal model ofpostmenopausal bone loss[J].Nippon Rinsho,2004,62(Suppl 2):759.
  • 3王军.年老性骨质疏松的危险因素、发病机制及防治[J].中国老年学杂志,2008,28(18):1869-1871. 被引量:8
  • 4Young R.Cell proliferation and specializatin duringendochondral osteogenesis in young rats[J].J Cell Biol,1962,14:357.
  • 5Chen J R,Plotkin L I,Agnirre J I,et al.Transient versussustained phosphorylation and nuclear accumulation ofERKs underlie anti-versus pro-apoptotic efects ofestrogens[J].J Biol Chem,2005,280:4632.
  • 6Zheng M H,Wood D J,Papadimitrion J M.What's newin the role of cytokines on osteoblast proliferation anddifferentiation[J].Pathol Res Pract,1992,188:1104.
  • 7Roodman G D.Advances in bone biology:the osteoclast[J].Endocr Rev,1996,17:308.
  • 8安贵峰,屠冠军.骨质疏松模型骨组织中IL-6,IL-1β,TNF-α的表达特征[J].中国医科大学学报,2005,34(2):97-99. 被引量:15
  • 9邓廉夫,何涛.骨质疏松症破骨细胞的形成与骨吸收活性的研究[J].江苏医药,2002,28(8):563-565. 被引量:9
  • 10郭世友.骨质疏松基础与临床[M].天津:天津科技出版社,2001:129.

二级参考文献19

  • 1柴本甫,汤雪明,李慧.髋部骨折患者中股骨颈松质骨的破骨细胞性骨吸收(扫描电镜观察)[J].中华骨科杂志,1995,15(5):291-294. 被引量:16
  • 2于明香,金慰芳,王洪复,关本博,林光义.破骨细胞体外培养与形态观察[J].上海医科大学学报,1996,23(1):52-54. 被引量:19
  • 3Griffin MG, Kimble R, Hopfer W, et al. Dual energy x-ray absorptiometry( DEXA )of the rat: accuracy , precision and measurement of bone loss[J]. J Bone Miner Res, 1993,8 (7) :795 - 797.
  • 4Kalu D N. The ovariectomized rat model of postmenopausal bone loss [J]. Bone and Mineral, 1991,15(3) :175 - 192.
  • 5Kimble RB, Srivastava S, Ross PF, et al. Estrogen deficiency increases the ability of stromal cell to support murine osteoclastogenesis via an interleukin-1 and tumor necrosis factor-mediated stimulation of macrophage colony stimulating factor production [J]. J Biol Chem,1996,271 (46) :28890 - 28897.
  • 6Strand V, Kavanaugh AF. The role ofinterleukin-1 in bone resorption in rheumatoid arthritis [J]. Rheumatology ( Oxford ), 2004,43(Suppl-3): Ⅲ10 - Ⅲ16.
  • 7Pfeilschifter J, Koditz R, Pfohl M, et al. Changes in proinflammatory cytokine activity after menopause [J]. Endocr Rev, 2002,23(1):90-119.
  • 8车明学,谷贵山,李福春.新型钙离子通道TRPV5在骨质疏松症发病机制中的作用[J].中国老年学杂志,2007,27(17):1732-1734. 被引量:6
  • 9Vlassara H, Recentprogress in advanced glycation end products and diabetic complications[J]. Diabetes, 1997 ;46( Suppl2 ) : 19-25.
  • 10Hein G. Glycation and products in osteoporosis-is there a pathophysiologic in progress[J]. Clinical Chinica Acta ,2006 ;371 (1-2 ) :32-6.

共引文献461

同被引文献212

引证文献7

二级引证文献126

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部